Monte Rosa Therapeutics Inc (GLUE)

May 24, 2025

Revenues Working Against Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) Share Price Following 26% Dive - simplywall.st

May 24, 2025

May 16, 2025

Dimensional Fund Advisors LP Has $1.01 Million Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 16, 2025

May 15, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stake Increased by Tower Research Capital LLC TRC - Defense World

May 15, 2025

May 10, 2025

Results: Monte Rosa Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

May 10, 2025

May 09, 2025

Monte Rosa Therapeutics Inc (GLUE)’s Day in Review: Closing at 4.22, Up by 9.61 - DWinneX

May 09, 2025

May 09, 2025

Barclays PLC Raises Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 09, 2025

May 09, 2025

Monte Rosa Therapeutics Reports Strong Q1 2025 Earnings - TipRanks

May 09, 2025

May 08, 2025

Monte Rosa Therapeutics: Q1 Earnings Snapshot - Greenwich Time

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics Reports Strong Q1 2025 Results - MSN

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates - MSN

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

May 08, 2025

MONTE ROSA THERAPEUTICS Earnings Results: $GLUE Reports Quarterly Earnings - Nasdaq

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics (GLUE) Advances Novel Therapeutic Progra - GuruFocus

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025

May 08, 2025

Monte Rosa Therapeutics (GLUE) Advances Novel Therapeutic Programs | GLUE Stock News - GuruFocus

May 08, 2025

May 06, 2025

Invesco Ltd. Purchases New Shares in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 06, 2025

May 05, 2025

Monte Rosa Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

JPMorgan Chase & Co. Acquires 5,551 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 05, 2025

May 04, 2025

Wells Fargo & Company MN Buys 47,952 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

May 04, 2025

Apr 28, 2025

Monte Rosa reports breakthrough in breast cancer treatment - Investing.com Australia

Apr 28, 2025

Apr 28, 2025

Monte Rosa reports breakthrough in breast cancer treatment By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

Monte Rosa Therapeutics (GLUE) to Unveil Promising Breast Cancer Data at AACR 2025 | GLUE Stock News - GuruFocus

Apr 28, 2025

Apr 28, 2025

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Breakthrough: New Molecular Glue Degrader Achieves 77% Tumor Shrinkage in Hard-to-Treat Breast Cancer - Stock Titan

Apr 28, 2025

Apr 26, 2025

Monte Rosa Therapeutics Inc (GLUE) Sits And Waits For Direction At $5.06 Price - Stocksregister

Apr 26, 2025

Apr 25, 2025

Geode Capital Management LLC Lowers Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 25, 2025

Apr 24, 2025

Can you now get a good deal on Monte Rosa Therapeutics Inc’s shares? - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Market Watch Highlights: Monte Rosa Therapeutics Inc (GLUE) Ends on an Upturn Note at 5.33 - DWinneX

Apr 24, 2025

Apr 24, 2025

GLUE’s 2023 Market Dance: Down -23.20% – Time to Invest? - investchronicle.com

Apr 24, 2025

Apr 22, 2025

How To Trade (GLUE) - news.stocktradersdaily.com

Apr 22, 2025

Apr 22, 2025

Monte Rosa Therapeutics Insider Ups Holding During Year - Yahoo Finance

Apr 22, 2025

Apr 20, 2025

Franklin Resources Inc. Buys Shares of 27,510 Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 20, 2025

Apr 16, 2025

Vanguard Group Inc. Buys 622,134 Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 16, 2025

Apr 14, 2025

Wellington Management Group LLP Grows Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 14, 2025

Apr 13, 2025

American Century Companies Inc. Has $533,000 Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 13, 2025

Apr 12, 2025

Sei Investments Co. Buys Shares of 17,236 Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Apr 12, 2025

Apr 06, 2025

How to Take Advantage of moves in (GLUE) - news.stocktradersdaily.com

Apr 06, 2025

Mar 29, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Holdings Boosted by Charles Schwab Investment Management Inc. - Defense World

Mar 29, 2025

Mar 27, 2025

Chandra Leo Spends US$58k On Monte Rosa Therapeutics Stock - simplywall.st

Mar 27, 2025

Mar 26, 2025

Monte Rosa Therapeutics director Leo Chandra buys $58,383 in stock By Investing.com - Investing.com India

Mar 26, 2025

Mar 25, 2025

Monte Rosa Therapeutics director Leo Chandra buys $58,383 in stock - Investing.com

Mar 25, 2025

Mar 25, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Position Lifted by Bank of New York Mellon Corp - Defense World

Mar 25, 2025

Mar 25, 2025

What is Wedbush’s Forecast for GLUE FY2029 Earnings? - The AM Reporter

Mar 25, 2025

Mar 24, 2025

Monte Rosa Therapeutics: Exercise Extreme Caution (NASDAQ:GLUE) - Seeking Alpha

Mar 24, 2025

Mar 24, 2025

FY2029 Earnings Estimate for GLUE Issued By Wedbush - Defense World

Mar 24, 2025